The deleterious side effects of the coronavirus disease 2019 (COVID-19) pandemic on cardiovascular disease have been widely reported [1–3]. However, most data refer to March and April 2020. Particularly, patients with ST-elevation myocardial infarction (STEMI) and concomitant infection presented the worst outcome and a significant prolongation in time to seek medical attention [4,5].
